bevacizumab,trifluridine tipiracil
taiho pharma,roche,otsuka
[]
more practice-changing research from #gi23: sunlight study finds adding bev to trifluridine/tipiracil in the treatment of refractory #mcrc improved median os compared w/ trifluridine/tipiracil alone: #ascodailynews #crcsm
Account of the American Society of Clinical Oncology & its affiliate the Association for Clinical Oncology. Assoc tweets labeled #ASCOAdvocacy. RTs ≠ endorse.